Identification of novel proteins induced by estradiol, 4-hydroxytamoxifen and acolbifene in T47D breast cancer cells.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Steroids

• Publication date

  2006-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.STEROIDS.2006.07.006PMID 16949628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomic analysis of neuroblastoma subtypes in response to mitogen-activated protein kinase inhibition: profiling multiple targets of cancer kinase signaling.

  2006cited by this paper
• The Role of Genetic Markers— NAP1L1, MAGE-D2, and MTA1—in Defining Small-Intestinal Carcinoid Neoplasia

  2006cited by this paper
• Protein Profiling of Bladder Cancer Using the 2D-PAGE and SELDI-TOF-MS Technique

  2006cited by this paper
• Proteomic analysis of prodigiosin-induced apoptosis in a breast cancer mitoxantrone-resistant (MCF-7 MR) cell line

  2006cited by this paper
• Two-dimensional electrophoresis database of fluorescence-labeled proteins of colon cancer cells.

  2005cited by this paper
• Influence of oestradiol and tamoxifen on oestrogen receptors-α and -β protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells

  2005cited by this paper
• Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: the two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses.

  2005cited by this paper
• Growth of MCF-7 human breast carcinoma in severe combined immunodeficient mice: Growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells

  2005cited by this paper
• Influence of oestradiol and tamoxifen on oestrogen receptors-alpha and -beta protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells.

  2005cited by this paper
• Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine.

  2004cited by this paper
• Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, γ‐synuclein, and catechol‐o‐methyltransferase) identified by proteomic analysis

  2004cited by this paper
• Altered gene expression in human cells induced by the agricultural chemical Enable

  2004cited by this paper
• Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancer.

  2004cited by this paper
• Expression of estrogen receptor coregulators in normal and malignant human endometrium.

  2004cited by this paper
• Selective estrogen receptor modulator regulated proteins in endometrial cancer cells.

  2004cited by this paper
• Selective Estrogen Receptor Modulators

  2004cited by this paper
• Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2

  2003cited by this paper
• Various Phosphorylation Pathways, Depending on Agonist and Antagonist Binding to Endogenous Estrogen Receptor α (ERα), Differentially Affect ERα Extractability, Proteasome-Mediated Stability, and Transcriptional Activity in Human Breast Cancer Cells

  2003cited by this paper
• Proteomic analysis of early melanosomes: identification of novel melanosomal proteins.

  2003cited by this paper
• Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer.

  2003cited by this paper
• Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.

  2003cited by this paper
• Resistance to different antiestrogens is caused by different multi-factorial changes and is associated with reduced expression of IGF receptor Ialpha.

  2003cited by this paper
• Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.

  2003cited by this paper
• Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.

  2003cited by this paper
• Ligand-Induced Regulation of ERα and ERβ is Indicative of Human Breast Cancer Cell Proliferation

  2003cited by this paper
• Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.

  2003cited by this paper
• Involvement of Nucleocytoplasmic Shuttling of Yeast Nap1 in Mitotic Progression

  2003cited by this paper
• Therapeutic effect of a single peritumoural dose of IL-2 on transplanted murine breast cancer

  2003cited by this paper
• Estrogen and growth factor signaling pathway: basic approaches for clinical application.

  2003cited by this paper
• Differential protein expression in the cytosol fraction of an MCF-7 breast cancer cell line selected for resistance toward melphalan.

  2002cited by this paper
• Progress in breast cancer chemoprevention.

  2002cited by this paper
• V490M, a Common Mutation in 3-Phosphoglycerate Dehydrogenase Deficiency, Causes Enzyme Deficiency by Decreasing the Yield of Mature Enzyme*

  2002cited by this paper
• EM-652 (SCH57068), a pure SERM having complete antiestrogenic activity in the mammary gland and endometrium.

  2001cited by this paper
• Mechanisms of estrogen action.

  2001cited by this paper
• Calreticulin Is a Receptor for Nuclear Export

  2001cited by this paper
• DNA binding domains in diverse nuclear receptors function as nuclear export signals.

  2001cited by this paper
• Cellular and molecular pharmacology of antiestrogen action and resistance.

  2001cited by this paper
• L‐Serine regulates the activities of microglial cells that express very low level of 3‐phosphoglycerate dehydrogenase, an enzyme for L‐serine biosynthesis

  2001cited by this paper
• Molecular markers for predicting response to tamoxifen in breast cancer patients

  2000cited by this paper
• Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo.

  2000cited by this paper
• The role of cathepsin D and PAI-1 in primary invasive breast cancer as prognosticators and predictors of treatment benefit with adjuvant tamoxifen.

  2000cited by this paper
• Cancer statistics, 2000

  2000cited by this paper
• Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms.

  2000cited by this paper
• Functional Interaction between Nucleosome Assembly Proteins and p300/CREB-Binding Protein Family Coactivators

  2000cited by this paper
• Chromatin assembly: biochemical identities and genetic redundancy.

  1999cited by this paper
• EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium.

  1999cited by this paper
• Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer.

  1999cited by this paper
• Evolving concepts of selective estrogen receptor action: from basic science to clinical applications.

  1999cited by this paper
• Comparative analyses of mechanistic differences among antiestrogens.

  1999cited by this paper
• Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth.

  1999cited by this paper
• The GYF domain is a novel structural fold that is involved in lymphoid signaling through proline-rich sequences

  1999cited by this paper
• Comparative Analyses of Mechanistic Differences Among Antiestrogens1.

  1999cited by this paper
• Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimeras.

  1998cited by this paper
• Absence of pyridoxine-5'-phosphate oxidase (PNPO) activity in neoplastic cells: isolation, characterization, and expression of PNPO cDNA.

  1998cited by this paper
• Estradiol-induced Phosphorylation of Serine 118 in the Estrogen Receptor Is Independent of p42/p44 Mitogen-activated Protein Kinase*

  1998cited by this paper
• Identification of a proline-binding motif regulating CD2-triggered T lymphocyte activation.

  1998cited by this paper
• HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.

  1998cited by this paper
• Basic guide to the mechanisms of antiestrogen action.

  1998cited by this paper
• Calreticulin: an intracellular Ca++-binding protein abundantly expressed and regulated by androgen in prostatic epithelial cells.

  1998cited by this paper
• Calreticulin: An Intracellular Ca++-Binding Protein Abundantly Expressed and Regulated by Androgen in Prostatic Epithelial Cells* * This work was supported by Boehringer Ingelheim International GmbH, American Cancer Society, Illinois Division Grant 95-58, the Robert H. Lurie Cancer Center Grant 200,

  1998cited by this paper
• Transcription Activation by the Human Estrogen Receptor Subtypeβ (ERβ) Studied with ERβ and ERα Receptor Chimeras* *This work was supported by NIH Grants CA-18119 and CA-60514 (to B.S.K.).

  1998cited by this paper
• Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies.

  1997cited by this paper
• Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.

  1997cited by this paper
• Different Regions in Activation Function-1 of the Human Estrogen Receptor Required for Antiestrogen- and Estradiol-dependent Transcription Activation*

  1996cited by this paper
• Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.

  1996cited by this paper
• Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.

  1995cited by this paper
• Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.

  1993cited by this paper
• Vitamin B6 modulates transcriptional activation by multiple members of the steroid hormone receptor superfamily.

  1992cited by this paper
• Interleukin-2 differentially affects the proliferation of a hormone-dependent and a hormone-independent human breast cancer cell line in vitro and in vivo.

  1988cited by this paper
• Enzymic imbalance in serine metabolism in human colon carcinoma and rat sarcoma.

  1988cited by this paper
• The modulation of serine metabolism in hepatoma 3924A during different phases of cellular proliferation in culture.

  1987cited by this paper
• Enzymic imbalance in serine metabolism in rat hepatomas.

  1986cited by this paper

• Sparse canonical correlation to identify breast cancer related genes regulated by copy number aberrations

  2021cites this paper
• Interplay of ERα binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of Cystatin A in breast cancer cells

  2019cites this paper
• Implications of the Sap47 null mutation for synapsin phosphorylation, longevity, climbing proficiency and behavioural plasticity in adult Drosophila

  2019cites this paper
• Pyridoxine 5′-phosphate oxidase is correlated with human breast invasive ductal carcinoma development

  2019cites this paper
• Nucleosome assembly proteins NAP1L1 and NAP1L4 modulate p53 acetylation to regulate cell fate.

  2019cites this paper
• NAP1L1 regulates NF-κB signaling pathway acting on anti-apoptotic Mcl-1 gene expression.

  2017cites this paper
• Pyridoxine 5′-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer

  2017cites this paper
• Initial characterization of a Syap1 knock-out mouse and distribution of Syap1 in mouse brain and cultured motoneurons

  2016cites this paper
• Gene expression profiling of mammary glands at an early stage of DMBA-induced carcinogenesis in the female Sprague-Dawley rat.

  2016cites this paper
• Comparative proteomics to investigate the in vitro antiproliferative effect of dietary polyphenols against K562 leukemia cells / Gıda kaynaklı polifenollerin K562 lösemi hücreleri üzerine in vitro çoğalmayı önleyici etkisinin karşılaştırmalı proteomik çalışmalarla incelenmesi

  2015cites this paper
• Phosphoglycerate Dehydrogenase: Potential Therapeutic Target and Putative Metabolic Oncogene

  2014cites this paper
• MicroRNAs: Novel Mechanism Involved in the Pathogenesis of Microwave Exposure on Rats’ Hippocampus

  2014cites this paper
• Calreticulin expression in infiltrating ductal breast carcinomas: relationships with disease progression and humoral immune responses

  2013cites this paper
• Nucleosome assembly proteins and their interacting proteins in neuronal differentiation.

  2013cites this paper
• Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231

  2013cites this paper
• Knockdown of nucleosome assembly protein 1‐like 1 promotes dimethyl sulfoxide‐induced differentiation of P19CL6 cells into cardiomyocytes

  2012cites this paper
• Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells

  2009cites this paper
• transcriptome and genome analyses Next-generation DNA sequencing of paired-end tags ( PET ) for

  2009cites this paper
• Next-generation DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses.

  2009cites this paper
• Gene Expression Profiling Reveals Putative HOXA10 Downstream Targets in the Periimplantation Mouse Uterus

  2008cites this paper
• Proline-rich sequence recognition domains (PRD): ligands, function and inhibition.

  2008cites this paper
• Fusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs).

  2007cites this paper